27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

Efficacy and Impact of the Melanocortin Receptor Agonists PL8177 and PL9654 in an STZ-Rat Model of Diabetic Retinopathy

Scroll to Top